Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

An Orthotopic Model of Serous Ovarian Cancer in Immunocompetent Mice for in vivo Tumor Imaging and Monitoring of Tumor Immune Responses

An Orthotopic Model of Serous Ovarian Cancer in Immunocompetent Mice for in vivo Tumor Imaging and Monitoring of Tumor Immune Responses

To study in vivo tumor growth and tumor microenvironment, we used a syngeneic and orthotopic mouse model of ovarian cancer in immunocompetent animals. We transduced a mouse tumor cell line (MOV1) with Katushka fluorescent protein (MOV1KAT) and here we show its orthotopic implantation in ovary and in vivo imaging.

Center of Mass: Introduction

Center of Mass: Introduction

Any object that obeys Newton's second law of motion is made up of a large number of infinitesimally small particles. Objects in motion can be as simple as atoms or as complex as gymnasts performing in the Olympics. The motion of such objects is described about a point called the center of mass of the object. The center of mass of an object is a point that acts as if the whole mass is concentrated at that point. The center of mass of an object with a large number of infinitesimally small...

Preparation of Mitochondria from Ovarian Cancer Tissues and Control Ovarian Tissues for Quantitative Proteomics Analysis

Preparation of Mitochondria from Ovarian Cancer Tissues and Control Ovarian Tissues for Quantitative Proteomics Analysis

This article presents a protocol of differential-speed centrifugation in combination with density gradient centrifugation to separate mitochondria from human ovarian cancer tissues and control ovarian tissues for quantitative proteomics analysis, resulting in a high-quality mitochondrial sample and high-throughput and high-reproducibility quantitative proteomics analysis of a human ovarian cancer mitochondrial...

Quantitation of Intra-peritoneal Ovarian Cancer Metastasis

Quantitation of Intra-peritoneal Ovarian Cancer Metastasis

Ovarian cancer metastasis is characterized by numerous diffuse intra-peritoneal lesions, such that accurate visual quantitation of tumor burden is challenging. Herein we describe a method for in situ and ex vivo quantitation of metastatic tumor burden using red fluorescent protein (RFP)-labeled tumor cells and optical...

Obtaining Primary Ovarian Cancer Cells from Solid Specimens: A Method to Culture Epithelial Ovarian Cancer Cells from Ovarian Tumor Specimens

Obtaining Primary Ovarian Cancer Cells from Solid Specimens: A Method to Culture Epithelial Ovarian Cancer Cells from Ovarian Tumor Specimens

In this video, we describe a method for isolating and characterizing primary ovarian cancer cells from solid ovarian tumor tissue specimens. The epithelial cancer cells obtained using this protocol are suitable for understanding the processes that may lead to ovarian cancer initiation and...

Method for Obtaining Primary Ovarian Cancer Cells From Solid Specimens

Method for Obtaining Primary Ovarian Cancer Cells From Solid Specimens

This study describes a detailed method for isolation and characterization of primary ovarian cancer cells from solid clinical specimens. Ovarian cancer clinical specimens are subjected to enzymatic digestion to obtain viable, fibroblast-free epithelial ovarian cancer (EOC) cells highly suitable for downstream...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Correction: PARP Inhibitors Differentially Regulate Immune Responses in Distinct Genetic Backgrounds of High-Grade Serous Tubo-Ovarian Carcinoma.

Cancer research communications·2025

Same author

Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer.

Cell·2025

Same author

Author Correction: Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus.

Nature communications·2025

Same author

Phase 2 Study of Zilovertamab Vedotin in Participants with Metastatic Solid Tumors.

Cancer research communications·2025

Same author

SMARCA4 Loss Increases RNA Polymerase II Pausing and Elevates R-Loops to Inhibit BRCA1-Mediated Repair in Ovarian Cancer.

Cancer research·2025

Same author

A Rapid and Reliable Test for <i>BRCA1</i> Promoter Hypermethylation in Paraffin Tissue Using Pyrosequencing.

Diagnostics (Basel, Switzerland)·2025

Same journal

Corrigendum to "Joint GOG-Foundation (GOG) and European Network of Gynaecological Oncological Trial Groups (ENGOT) clinical trials guidance for operations with industry partners" [International Journal of Gynecological Cancer 36 (2026) 104753].

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2026

Same journal

piR-hsa-8111406 promotes proliferation and serves as a novel biomarker for early detection of ovarian cancer: a multi-center retrospective study.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2026

Same journal

Poly(adenosine diphosphate-ribose) polymerase inhibitor maintenance therapy with niraparib in patients with primary advanced or recurrent endometrial cancer receiving dostarlimab plus chemotherapy.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2026

Same journal

Balancing fertility potential and oncologic and obstetric risks: a vignette study on decision-making in fertility-sparing surgery for early-stage cervical cancer.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2026

Same journal

Updated pocket guide for integrated risk stratification in endometrial carcinoma: a practical tool based on European Society of Gynecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology 2025 guidelines.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2026

Same journal

How long is enough? Immunotherapy duration in mismatch repair deficient endometrial cancer.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jan 20, 2026

An Orthotopic Model of Serous Ovarian Cancer in Immunocompetent Mice for in vivo Tumor Imaging and Monitoring of Tumor Immune Responses

An Orthotopic Model of Serous Ovarian Cancer in Immunocompetent Mice for in vivo Tumor Imaging and Monitoring of Tumor Immune Responses

Published on: November 28, 2010

Introduction: the 12th Biennial Rivkin Center Ovarian Cancer Research Symposium.

Nita J Maihle¹, Douglas A Levine², Kiran Dhillon³

¹University of Mississippi Medical Center, Jackson, Mississippi, USA.

International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society

|August 30, 2019

Summary

This summary is machine-generated.

The 2018 Ovarian Cancer Research Symposium highlighted key advances in early detection, molecular mechanisms, tumor immunology, and novel treatments for ovarian cancer. Patient advocacy was also a key focus, emphasizing collaborative research efforts.

Area of Science:

Gynecology
Oncology
Translational Research

Background:

The 12th Biennial Ovarian Cancer Research Symposium convened in September 2018, focusing on critical advancements in ovarian cancer research.

Keywords:

AACR ovarian cancer research rivkin center

More Related Videos

Preparation of Mitochondria from Ovarian Cancer Tissues and Control Ovarian Tissues for Quantitative Proteomics Analysis

Preparation of Mitochondria from Ovarian Cancer Tissues and Control Ovarian Tissues for Quantitative Proteomics Analysis

Published on: November 18, 2019

Quantitation of Intra-peritoneal Ovarian Cancer Metastasis

Quantitation of Intra-peritoneal Ovarian Cancer Metastasis

Published on: July 18, 2016

Related Experiment Videos

Last Updated: Jan 20, 2026

An Orthotopic Model of Serous Ovarian Cancer in Immunocompetent Mice for in vivo Tumor Imaging and Monitoring of Tumor Immune Responses

An Orthotopic Model of Serous Ovarian Cancer in Immunocompetent Mice for in vivo Tumor Imaging and Monitoring of Tumor Immune Responses

Published on: November 28, 2010

Preparation of Mitochondria from Ovarian Cancer Tissues and Control Ovarian Tissues for Quantitative Proteomics Analysis

Preparation of Mitochondria from Ovarian Cancer Tissues and Control Ovarian Tissues for Quantitative Proteomics Analysis

Published on: November 18, 2019

Quantitation of Intra-peritoneal Ovarian Cancer Metastasis

Quantitation of Intra-peritoneal Ovarian Cancer Metastasis

Published on: July 18, 2016

The symposium was jointly presented by the Rivkin Center for Ovarian Cancer and the American Association for Cancer Research.